Radiation Bio-Protectant

Biotech companies say they're on the cusp of developing "radioprotectants," drugs that guard against acute radiation syndrome. Since most people who die in a nuclear attack do so from radiation sickness, these drugs promise great benefits as safeguards against nuclear terrorism. If they work, they would be unprecedented. It goes without saying that the federal government should be doing its utmost to promote them.

Promising.